BridgeBio
formerly BridgeBio PharmaIPOWe exist to bring meaningful medicines to patients quickly & safely.
Public · San Francisco Bay Area, United States · Founded 2014 · $2.7B raised
- Headquarters
- San Francisco Bay Area, California
- Employees
- 201–500
- Founded
- 2014
- Business Model
- Other
- Website
- bridgebio.com
- Total Funding
- $2.7B
- Last Round
- $1.0B Growth EquityJul 2026
- Rounds
- 6
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
BridgeBio is a biotechnology company designing transformative medicines for patients with genetic diseases and cancers with clear genetic drivers. It has a late-stage investigational pipeline including Acoramidis for ATTRv, BBP-418 for LGMD2I/R9, Encaleret for ADH1 and hypoparathyroidism, Infigratinib for achondroplasia and hypochondroplasia, and BBP-812 for Canavan Disease.
Summary
BridgeBio is a Biotech company based in San Francisco Bay Area, United States, founded in 2014. It has raised $2.7B in total across 6 rounds, most recently a $1.0B Growth Equity round in Jul 2026. Investors include Blue Owl Capital, KKR and Viking Global.
Tech & App Stack
11 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding & Exit History
Jul 2026
Sign up to see all 9 events
Funding: Series C through Growth Equity. Amounts, valuations, and investors where available.
Investors
Blue Owl Capital
2 rounds
KKR
2 rounds
Viking Global
2 rounds
Sixth Street
1 round
Canada Pension Plan Investment Board
1 round
Qatar Investment Authority
1 round
Healthcare Royalty Partners
1 round
HCRx
1 round
Sequoia Capital
1 round
Perceptive Advisors
1 round
AIG
1 round
Aisling Capital
1 round
Cormorant Asset Management
1 round
Similar Companies
Altos Labs combines academic science and industry development to create medicines that restore ce...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Calico researches human aging using advanced technologies and model systems, applying that knowle...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/bridgebio"><img src="https://indexed.vc/api/badge/company/bridgebio" alt="BridgeBio on Indexed.vc" width="260" height="76" /></a>